These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 826996)

  • 1. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo release of newly synthesized GABA in the basal ganglia of the cat.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Adv Biochem Psychopharmacol; 1981; 29():183-91. PubMed ID: 7257927
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nigrostriatal system as a source of torsion extrapyramidal disorders (review)].
    Arushanian EB; Dutov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):930-8. PubMed ID: 6774537
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.
    Stadler H; Lloyd KG; Gadea-Ciria M; Bartholini G
    Brain Res; 1973 Jun; 55(2):476-80. PubMed ID: 4351628
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects of dopamine in the basal ganglia.
    Carlsson A
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():181-9. PubMed ID: 12545
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effect of dopamine on acetylcholine release from caudate nucleus.
    Vizi SE; Rónai A; Hársing L; Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):201-11. PubMed ID: 887499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 11. On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.
    Moroni F; Peralta E; Cheney DL; Costa E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):190-4. PubMed ID: 762651
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochemical and electrophysiological studies of dopamine in the caudate nucleus.
    Siggins GR; Hoffer BJ; Bloom FE; Ungerstedt U
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():227-48. PubMed ID: 188086
    [No Abstract]   [Full Text] [Related]  

  • 13. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic pallidonigral and "accessory" striatonigral connections demonstrated in cats by double peroxidase labeling.
    Fisher RS
    Synapse; 1989; 4(2):165-7. PubMed ID: 2476865
    [No Abstract]   [Full Text] [Related]  

  • 18. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of [3H]GABA release: an approach to the study of the regulation of GABA-containing neurons in the basal ganglia and associated structures in the cat and the rat.
    Besson MJ; Kemel ML; Gauchy C; Girault JA; Spampinato U; Lantin N; Desban M; Glowinski J
    Ann N Y Acad Sci; 1986; 473():475-88. PubMed ID: 3541740
    [No Abstract]   [Full Text] [Related]  

  • 20. Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1978 Apr; 48(3):281-95. PubMed ID: 639856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.